Sign in / Join Now
ETFs & Funds
Teva: Undervalued Industry Leading Generic Drug Maker At 7.5X Adjusted
Agree but watch entry price; testing results, Israeli/ Iran jitters etc.have swung to $35 recently; I add as it hits $37-39 during meltdowns
Mercy, not a bad entry point. Healthcare sector undervalued relative to its historical multiples and has held up well in the last few months
Add a reply...
Latest StockTalks »
people get EPS breaking news and analysis by email alert.
Get email alerts on EPS »
WisdomTree Earnings 500 ETF
Get latest price
From other sites
Eastplats Announces Appointment Of Mr. Rowland Wallenius As Chief Financial Officer And Corporate Secretary
at TheStreet (Nov 28, 2016)
Eastern Platinum Limited Reports Third Quarter 2016 Financial Results And Updates On Other Developments
at TheStreet (Nov 14, 2016)